These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6859297)

  • 1. Major depression in the elderly: DSM-III criteria and the dexamethasone suppression test as predictors of treatment response.
    Spar JE; La Rue A
    Am J Psychiatry; 1983 Jul; 140(7):844-7. PubMed ID: 6859297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between the dexamethasone suppression test in depressed patients and clinical response.
    Nemeroff CB; Evans DL
    Am J Psychiatry; 1984 Feb; 141(2):247-9. PubMed ID: 6691487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dexamethasone suppression test, poststroke depression, and the validity of DSM-III-based diagnostic criteria.
    Ross ED; Gordon WA; Hibbard M; Egelko S
    Am J Psychiatry; 1986 Sep; 143(9):1200-1. PubMed ID: 3752314
    [No Abstract]   [Full Text] [Related]  

  • 4. Serial dexamethasone suppression tests in initial suppressors and nonsuppressors treated with electroconvulsive therapy.
    Devanand DP; Decina P; Sackeim HA; Hopkins N; Novacenko H; Malitz S
    Biol Psychiatry; 1987 Apr; 22(4):463-72. PubMed ID: 3567261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The implications of DSM-III personality disorders for patients with major depression.
    Pfohl B; Stangl D; Zimmerman M
    J Affect Disord; 1984 Dec; 7(3-4):309-18. PubMed ID: 6241212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of four definitions of melancholia by the dexamethasone suppression test.
    Davidson J; Lipper S; Zung WW; Strickland R; Krishnan R; Mahorney S
    Am J Psychiatry; 1984 Oct; 141(10):1220-3. PubMed ID: 6486256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome following ECT for primary unipolar depression: a test of newly proposed response predictors.
    Coryell W; Zimmerman M
    Am J Psychiatry; 1984 Jul; 141(7):862-7. PubMed ID: 6731634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depression and dexamethasone suppression testing in children and adolescents.
    Emslie GJ; Weinberg WA; Rush AJ; Weissenburger J; Parkin-Feigenbaum L
    J Child Neurol; 1987 Jan; 2(1):31-7. PubMed ID: 3624827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Problems with diagnostic criteria for depression.
    Carroll BJ
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):14-8. PubMed ID: 6376481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone suppression test and treatment response.
    Gitlin MJ; Gwirtsman H; Fairbanks L; Sternbach HA; Cedars PI; Gerner RH
    J Clin Psychiatry; 1984 Sep; 45(9):387-9. PubMed ID: 6469923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dexamethasone suppression test as a monitor of clinical recovery.
    Peselow ED; Baxter N; Fieve RR; Barouche F
    Am J Psychiatry; 1987 Jan; 144(1):30-5. PubMed ID: 3799836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility.
    Greden JF; Gardner R; King D; Grunhaus L; Carroll BJ; Kronfol Z
    Arch Gen Psychiatry; 1983 May; 40(5):493-500. PubMed ID: 6340634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment dexamethasone suppression test as a predictor of response to phenelzine.
    Janicak PG; Pandey GN; Sharma R; Boshes R; Bresnahan D; Davis JM
    J Clin Psychiatry; 1987 Dec; 48(12):480-2. PubMed ID: 3693333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone suppression test and subcategories of DSM-III major depression.
    Kitamura T; Shima S; Shikano T; Kano S; Asai M; Itoh H
    Psychopathology; 1985; 18(4):198-200. PubMed ID: 4089118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A longitudinal evaluation of dexamethasone and cortisol plasma concentrations in the dexamethasone suppression test before and during treatment with antidepressant drugs.
    Guthrie SK; Vartanian L; Grunhaus L; Hariharan M; Pande A; Haskett RF
    Acta Psychiatr Scand; 1990 Dec; 82(6):427-32. PubMed ID: 2291411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four definitions of endogenous depression and the dexamethasone suppression test.
    Zimmerman M; Coryell W; Pfohl B; Stangl D
    J Affect Disord; 1985; 8(1):37-45. PubMed ID: 3156910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dexamethasone suppression test and ECT outcome: a six-month follow-up.
    Coryell W; Zimmerman M
    Biol Psychiatry; 1983 Jan; 18(1):21-7. PubMed ID: 6830923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of DSM-III and ICD-8 diagnoses for major affective disorders and the use of biological markers for depression.
    Malt U; Pape-Ellefsen E; Vestergaard P
    Acta Psychiatr Scand Suppl; 1986; 328():35-44. PubMed ID: 3092584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DST results in nonpsychotic depressed outpatients.
    Khan A; Johnson F; Avery DH; Cohen S; Scherzo B; Dunner DL
    Am J Psychiatry; 1988 Sep; 145(9):1153-6. PubMed ID: 3046385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anorexia nervosa and depression: a dissenting view.
    Altshuler KZ; Weiner MF
    Am J Psychiatry; 1985 Mar; 142(3):328-32. PubMed ID: 3882007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.